Trulicity 0.75 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F47CK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,544
Award facts
- Contract value 100% obligated
- $13,543.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,543.55 delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on January 7, 2026, with completion targeted for January 8, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication used to improve blood sugar control in patients with type 2 diabetes, reflecting the Defense Logistics Agency's ongoing need to supply pharmaceutical products to military and veteran healthcare systems.
This delivery order was issued under AmerisourceBergen's parent company Cencora, Inc.'s broader Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion single-award vehicle established through December 2031. This comprehensive IDC enables the delivery of a wide spectrum of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs globally. AmerisourceBergen's consistent receipt of competitively awarded delivery orders demonstrates its established capability to meet federal procurement requirements for critical pharmaceutical commodities across multiple therapeutic domains serving the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F47CK?
SPE2DR26F47CK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F47CK worth?
The government has obligated $13,544 on SPE2DR26F47CK.
Is contract SPE2DR26F47CK an order under another contract?
Yes. SPE2DR26F47CK is a delivery order under SPE2DR25D2101, an indefinite delivery contract.
Was contract SPE2DR26F47CK competed?
The extent of competition for SPE2DR26F47CK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award